Clinical trial · Interventional
Shared Decision Making With Breast Cancer Patients
Shared Decision Making With Breast Cancer Patients Offered Adjuvant Radiotherapy
NCT04177628CI-TRIAL-00070972completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this project is to elucidate whether the use of shared decision making will influence patient engagement in the decision making process about adjuvant radiotherapy after breast conserving surgery for local breast cancer or early stages of local breast cancer.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Neoplasms | Breast Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Radiotherapy, Adjuvant | — | UNRESOLVED | — |
| Shared Decision Making | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Shared decision making supported by an in-consultation patient decision aid | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Arm A: Shared decision making
- description
- Patients will be informed by a doctor randomized to practice shared decision making and use the in-consultation PtDA during the consultation on adjuvant radiotherapy.
- interventionNames
- Behavioral: Shared decision making supported by an in-consultation patient decision aid
- type
- NO_INTERVENTION
- label
- Arm B: Usual practice
- description
- Patients will be informed by a doctor randomized to inform about adjuvant radiotherapy according to usual practice.
Primary outcomes (1)
- measure
- Participant engagement in the decision making process as measured by the Shared Decision Making Questionnaire 9.
- timeFrame
- Within one week after the consultation
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Histologically verified breast cancer or ductal carcinoma in situ breast cancer * Candidate for adjuvant radiotherapy Danish Breast Cancer Group type F after breast-conserving surgery for T1-2, N0-Nmi, M0 disease according to national guidelines. * Signed confirmation of participation. Exclusion Criteria: * Bilateral breast cancer or suspicion of disseminated cancer * Unable to understand the information, the planned treatment or follow-up for any reason. * Earlier radiotherapy towards the thoracic region.
References
Publications (0)
Data not yet available
No reference posted for this study.